Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report 2022: Rising Number Of Veterinarians And Veterinary Visits Boosts Growth
Retrieved on:
Monday, January 23, 2023
USD, Government, Assessment, Federation, RDNA, Veterinarian, Education, Animal, Zoonosis, Science and Technology Information Center (Ethiopia), Health, Obesity, Growth, Cancer, Administrative Department of Science, Technology and Innovation, Prevalence, API, Arthritis, Organization, Fine chemical, Vaccine
The global veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 10.64 billion by 2030.
Key Points:
- The global veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 10.64 billion by 2030.
- The key factors driving the industry growth include the growing animal population, rising pet ownership & humanization, high pet expenditure, an increasing number of veterinarians & veterinary visits, and a high prevalence of zoonotic diseases.
- In addition, the rising demand for pet insurance, strategic initiatives undertaken by key participants, and government initiatives are likely to boost industry growth.Various government policies are affecting the veterinary active pharmaceutical ingredients (API) manufacturing.
- For instance, in India, despite a strong base, domestic veterinary pharmaceutical companies have gradually stopped manufacturing veterinary APIs due to low-profit margins.